About Hematologische Onkologische Praxis
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
German CLL Study Group
3
German High-Grade Non-Hodgkin's Lymphoma Study Group
3
Hoffmann-La Roche
2
Heidelberg University
1
III. Medizinische Klinik Mannheim
1
Clinical Trials at Hematologische Onkologische Praxis
During the past decade, Hematologische Onkologische Praxis conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
2002-06-01
2017-03-31
Completed
1,551
Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
1997-04-01
2010-06-01
Completed
877
Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia
2005-11-01
2011-03-01
Completed
195
Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia
2004-09-01
2010-10-01
Completed
97
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hematologische Onkologische Praxis" #1 sponsor was "German CLL Study Group" with 3 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials
sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Heidelberg University" with 1 trials sponsored and "III. Medizinische Klinik Mannheim"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hematologische Onkologische Praxis"
#1 collaborator was "University of Cologne" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hematologische Onkologische Praxis
According to Clinical.Site data, the most researched conditions in "Hematologische Onkologische Praxis" are
"Chronic Lymphocytic Leukemia" (4 trials), "Lymphoma" (3 trials), "Leukemia" (2 trials), "Anemia" (1 trials) and "Non-Small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "Hematologische Onkologische Praxis" in a lesser frequency.
Clinical Trials Intervention Types at Hematologische Onkologische Praxis
Most popular intervention types in "Hematologische Onkologische Praxis" are "Drug" (10 trials), "Biological" (7 trials), "Radiation" (4 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (4 trials), "radiation therapy" (4 trials), "doxorubicin hydrochloride" (3 trials), "filgrastim" (3 trials) and "prednisone" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Hematologische Onkologische Praxis
The vast majority of trials in "Hematologische Onkologische Praxis" are
10 trials for "All" genders.
Clinical Trials Status at Hematologische Onkologische Praxis
Currently, there are NaN active trials in "Hematologische Onkologische Praxis".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Hematologische Onkologische Praxis,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hematologische Onkologische Praxis, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".